Skip to Content

Spinal Cord Stimulation May Ease Diabetic Nerve Pain

TUESDAY, Nov. 10, 2020 -- Low-frequency spinal cord stimulation (SCS) may be effective for treating painful diabetic neuropathy (DN), according to a study scheduled for presentation at the 19th Annual Pain Medicine Meeting, a meeting of the American Society of Regional Anesthesia and Pain Medicine, held virtually from Nov. 20 to 22.

Erika Petersen, M.D., from the University of Arkansas for Medical Sciences in Fayetteville, and colleagues randomly assigned (1:1) 216 patients with painful DN for ≥12 months to 10 kHz SCS (Nevro Corp.) combined with conventional medical management (CMM) or CMM alone (103 patients). This is an interim analysis and follow-up will last for 24 months.

The researchers found no reported study-related adverse events in the control group and 16 study-related adverse events in the SCS+CMM group. There were two procedure-related infections in the 10 kHz SCS+CMM group, yielding a 1.8 percent infection rate. There was a significant difference between the treatment groups with respect to achieving ≥50 percent pain relief and without worsening baseline neurological deficit. At three-month follow-up, there were also differences noted in lower-limb pain scores, responder rates, and investigator-assessed sensory improvements. Similar improvements were seen for the treatment groups across several health-related quality-of-life and functional measures, including the impact of pain on sleep and Global Impression of Change.

"These early results are encouraging for painful DN patients who are refractory to conventional care," the authors write.

Several authors disclosed financial ties to the medical device industry.

Abstract

More Information

© 2021 HealthDay. All rights reserved.

Posted: November 2020

Read this next

Oily Fish Consumption Tied to Lower Type 2 Diabetes Risk

FRIDAY, Jan. 22, 2021 -- Consumption of oily fish, but not nonoily fish, is associated with a lower risk for type 2 diabetes (T2D), according to a study published online Jan. 11...

Retinal Changes Linked to Cognitive Function in T1DM Patients

WEDNESDAY, Jan. 20, 2021 -- Abnormalities detected on noninvasive retinal imaging are associated with markers of cognitive dysfunction in older individuals with type 1 diabetes,...

More Diabetes Remission in T2DM Seen With Low-Carb Diets for Six Months

THURSDAY, Jan. 14, 2021 -- Patients with type 2 diabetes adhering to low-carbohydrate diets (LCDs) for six months may experience greater rates of diabetes remission, according to...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.